'
Zydus
Lifesciences hosted a conference call on May 20, 2025. In the conference call,
the company was represented by, Dr. Sharvil Patel, Managing Director.
Key takeaways of the call
In
Q4 FY25, the India Formulations business grew by 10.7% YoY, Consumer Wellness
was up 17.1%, US Formulations rose 24.1%, and International Formulations
increased 11.8%. However, revenue from the API segment declined by 10.2% YoY,
and the Alliances & Others segment was down 22.7% YoY.
In
FY25, the India Formulations business grew by 10.1% YoY, Consumer Wellness was
up 16.5%, US Formulations rose 27.2%, and International Formulations increased
13.8%. However, revenue from the API segment declined by 1% YoY, and the
Alliances & Others segment increased 3.8% YoY.
In
India Formulations segment, Branded business outperformed Indian Pharmaceutical
Market in Q4 FY25 driven by high uptick in pilla...
Pleaselogin & subscribe to view the full report.
More Reports
-
(05-Feb-2025)
Castrol India
Expects EBITDA margin of 22%-25% for CY25
-
(10-Feb-2023)
Deepak Nitrite
Plans capex of about Rs 1500 crore for FY23 and FY24
-
(09-Feb-2023)
Mayur Uniquoters
Targets revenue of Rs 1000 crore in FY24
-
(31-Jan-2023)
Tega industries
Capex plan is US$ 30-32 million for next three years
|
|